A citation-based method for searching scientific literature


List of co-cited articles
45 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
Jessica R Castle, Joseph El Youssef, Leah M Wilson, Ravi Reddy, Navid Resalat, Deborah Branigan, Katrina Ramsey, Joseph Leitschuh, Uma Rajhbeharrysingh, Brian Senf,[...]. Diabetes Care 2018
70
50

Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
Ahmad Haidar, Laurent Legault, Laurence Matteau-Pelletier, Virginie Messier, Maryse Dallaire, Martin Ladouceur, Rémi Rabasa-Lhoret. Lancet Diabetes Endocrinol 2015
78
50

Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog.
Ulrike Hövelmann, Britta Væver Bysted, Ulrik Mouritzen, Francesca Macchi, Daniela Lamers, Birgit Kronshage, Daniél Vega Møller, Tim Heise. Diabetes Care 2018
44
50

Pursuit of a perfect insulin.
Alexander N Zaykov, John P Mayer, Richard D DiMarchi. Nat Rev Drug Discov 2016
119
33

Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide.
Jonas Kildegaard, Stephen T Buckley, Rasmus H Nielsen, Gro K Povlsen, Torben Seested, Ulla Ribel, Helle B Olsen, Svend Ludvigsen, Claus B Jeppesen, Hanne H F Refsgaard,[...]. Pharm Res 2019
34
33


Glucose-responsive insulin by molecular and physical design.
Naveed A Bakh, Abel B Cortinas, Michael A Weiss, Robert S Langer, Daniel G Anderson, Zhen Gu, Sanjoy Dutta, Michael S Strano. Nat Chem 2017
53
33

Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
Bruce W Bode, Joseph A Johnson, Liselotte Hyveled, Søren C Tamer, Marek Demissie. Diabetes Technol Ther 2017
44
33

Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia.
Jinqiang Wang, Jicheng Yu, Yuqi Zhang, Anna R Kahkoska, Zejun Wang, Jun Fang, Julian P Whitelegge, Song Li, John B Buse, Zhen Gu. Proc Natl Acad Sci U S A 2019
20
33

Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study.
Matthew C Riddle, Rajaa Nahra, Jenny Han, Jessica Castle, Kathryn Hanavan, Marcus Hompesch, David Huffman, Poul Strange, Peter Öhman. Diabetes Care 2018
24
33

Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates.
Danny Hung-Chieh Chou, Matthew J Webber, Benjamin C Tang, Amy B Lin, Lavanya S Thapa, David Deng, Jonathan V Truong, Abel B Cortinas, Robert Langer, Daniel G Anderson. Proc Natl Acad Sci U S A 2015
106
33

A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Ahmad Haidar, Michael A Tsoukas, Sarah Bernier-Twardy, Jean-Francois Yale, Joanna Rutkowski, Anne Bossy, Evelyne Pytka, Anas El Fathi, Natalia Strauss, Laurent Legault. Diabetes Care 2020
42
33

Physico-chemical properties of co-formulated fast-acting insulin with pramlintide.
Dayana Cabral da Silva, Luís Maurício T R Lima. Int J Pharm 2018
11
33

BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.
Tim Heise, Grégory Meiffren, Bertrand Alluis, Cyril Seroussi, Aymeric Ranson, Jorge Arrubla, José Correia, Martin Gaudier, Olivier Soula, Rémi Soula,[...]. Diabetes Obes Metab 2019
21
33

The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes.
Rubina A Heptulla, Luisa M Rodriguez, Lisa Bomgaars, Morey W Haymond. Diabetes 2005
62
33

Chemically controlled closed-loop insulin delivery.
Valérie Ravaine, Christophe Ancla, Bogdan Catargi. J Control Release 2008
113
33

A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs.
Caitlin L Maikawa, Anton A A Smith, Lei Zou, Gillie A Roth, Emily C Gale, Lyndsay M Stapleton, Sam W Baker, Joseph L Mann, Anthony C Yu, Santiago Correa,[...]. Nat Biomed Eng 2020
22
33

Novel four-disulfide insulin analog with high aggregation stability and potency.
Xiaochun Xiong, Alan Blakely, Prasoona Karra, Michael A VandenBerg, Gabrielle Ghabash, Frank Whitby, Yi Wolf Zhang, Matthew J Webber, William L Holland, Christopher P Hill,[...]. Chem Sci 2019
9
33

Comparative Pharmacokinetic/Pharmacodynamic Study of Liquid Stable Glucagon Versus Lyophilized Glucagon in Type 1 Diabetes Subjects.
Jessica R Castle, Joseph El Youssef, Deborah Branigan, Brett Newswanger, Poul Strange, Martin Cummins, Leon Shi, Steven Prestrelski. J Diabetes Sci Technol 2016
22
33


Use of antidiabetic drugs in the U.S., 2003-2012.
Christian Hampp, Vicky Borders-Hemphill, David G Moeny, Diane K Wysowski. Diabetes Care 2014
149
33

Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetes.
Grit Andersen, Grégory Meiffren, Daniela Lamers, J Hans DeVries, Aymeric Ranson, Cyril Seroussi, Bertrand Alluis, Martin Gaudier, Olivier Soula, Tim Heise. Diabetes Obes Metab 2018
25
33


Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
Firas H El-Khatib, Courtney Balliro, Mallory A Hillard, Kendra L Magyar, Laya Ekhlaspour, Manasi Sinha, Debbie Mondesir, Aryan Esmaeili, Celia Hartigan, Michael J Thompson,[...]. Lancet 2017
122
33

Efficacy of the Diabeloop closed-loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exercise.
Hélène Hanaire, Sylvia Franc, Sophie Borot, Alfred Penfornis, Pierre-Yves Benhamou, Pauline Schaepelynck, Eric Renard, Bruno Guerci, Nathalie Jeandidier, Chantal Simon,[...]. Diabetes Obes Metab 2020
13
33

Coming of age: the artificial pancreas for type 1 diabetes.
Hood Thabit, Roman Hovorka. Diabetologia 2016
94
33

Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia.
Marc Breton, Anne Farret, Daniela Bruttomesso, Stacey Anderson, Lalo Magni, Stephen Patek, Chiara Dalla Man, Jerome Place, Susan Demartini, Simone Del Favero,[...]. Diabetes 2012
175
33


Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.
P G Jacobs, J El Youssef, R Reddy, N Resalat, D Branigan, J Condon, N Preiser, K Ramsey, M Jones, C Edwards,[...]. Diabetes Obes Metab 2016
65
33

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes.
Revital Nimri, Tadej Battelino, Lori M Laffel, Robert H Slover, Desmond Schatz, Stuart A Weinzimer, Klemen Dovc, Thomas Danne, Moshe Phillip. Nat Med 2020
18
33

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, Bruce A Buckingham, Bruce W Bode, Timothy S Bailey, Ronald L Brazg, Jacob Ilany, Robert H Slover, Stacey M Anderson,[...]. Diabetes Technol Ther 2017
273
33

Human Type 1 Diabetes Is Characterized by an Early, Marked, Sustained, and Islet-Selective Loss of Sympathetic Nerves.
Thomas O Mundinger, Qi Mei, Alan K Foulis, Corinne L Fligner, Rebecca L Hull, Gerald J Taborsky. Diabetes 2016
40
33

Advances in β-cell replacement therapy for the treatment of type 1 diabetes.
Marie-Christine Vantyghem, Eelco J P de Koning, François Pattou, Michael R Rickels. Lancet 2019
50
33


Pancreatic Extracts in the Treatment of Diabetes Mellitus.
F G Banting, C H Best, J B Collip, W R Campbell, A A Fletcher. Can Med Assoc J 1922
350
33

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.
Eleni Bekiari, Konstantinos Kitsios, Hood Thabit, Martin Tauschmann, Eleni Athanasiadou, Thomas Karagiannis, Anna-Bettina Haidich, Roman Hovorka, Apostolos Tsapas. BMJ 2018
164
33

Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus.
Ulrike Hövelmann, Minna Braendholt Olsen, Ulrik Mouritzen, Daniela Lamers, Birgit Kronshage, Tim Heise. Diabetes Obes Metab 2019
13
33


Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.
Morey W Haymond, Stephanie N DuBose, Michael R Rickels, Howard Wolpert, Viral N Shah, Jennifer L Sherr, Ruth S Weinstock, Shivani Agarwal, Alandra S Verdejo, Martin J Cummins,[...]. J Clin Endocrinol Metab 2017
21
33

A bihormonal closed-loop artificial pancreas for type 1 diabetes.
Firas H El-Khatib, Steven J Russell, David M Nathan, Robert G Sutherlin, Edward R Damiano. Sci Transl Med 2010
233
33

Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use.
Nadine Taleb, Ahmad Haidar, Virginie Messier, Véronique Gingras, Laurent Legault, Rémi Rabasa-Lhoret. Diabetes Obes Metab 2017
33
33

Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels.
Joseph El Youssef, Jessica R Castle, Parkash A Bakhtiani, Ahmad Haidar, Deborah L Branigan, Matthew Breen, W Kenneth Ward. Diabetes Care 2014
33
33

Pharmacokinetics and pharmacodynamics of various glucagon dosages at different blood glucose levels.
H Blauw, I Wendl, J H DeVries, T Heise, T Jax. Diabetes Obes Metab 2016
27
33

Efficacy determinants of subcutaneous microdose glucagon during closed-loop control.
Steven J Russell, Firas H El-Khatib, David M Nathan, Edward R Damiano. J Diabetes Sci Technol 2010
25
33

Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.
Jicheng Yu, Yuqi Zhang, Yanqi Ye, Rocco DiSanto, Wujin Sun, Davis Ranson, Frances S Ligler, John B Buse, Zhen Gu. Proc Natl Acad Sci U S A 2015
326
16

Insulin delivery systems combined with microneedle technology.
Xuan Jin, Dan Dan Zhu, Bo Zhi Chen, Mohammad Ashfaq, Xin Dong Guo. Adv Drug Deliv Rev 2018
84
16

The use of animal models in diabetes research.
Aileen J F King. Br J Pharmacol 2012
564
16

Mechanism of insulin aggregation and stabilization in agitated aqueous solutions.
V Sluzky, A M Klibanov, R Langer. Biotechnol Bioeng 1992
134
16

Extreme Adhesion Activity of Amyloid Fibrils Induces Subcutaneous Insulin Resistance.
Makoto Nakamura, Yohei Misumi, Toshiya Nomura, Wakana Oka, Aito Isoguchi, Kyosuke Kanenawa, Teruaki Masuda, Taro Yamashita, Yasuteru Inoue, Yukio Ando,[...]. Diabetes 2019
7
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.